Zyrexal

Zyrexal

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company

Vivera Pharmaceuticals, Inc.

DUNS: 081244342

Effective Date

February 10, 2020

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Active Ingredients

Folic acid(1 mg in 1 1)

Vitamin C(125 mg in 1 1)

Thiamine(25 mg in 1 1)

Mecobalamin(1 mg in 1 1)

Nicotinamide(60 mg in 1 1)

Pyridoxine(12.5 mg in 1 1)

.beta.-d-ribose(50 mg in 1 1)

Coenzyme Q10(75 mg in 1 1)

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Product Details

NDC Product Code

72380-915

Route of Administration

ORAL

Effective Date

February 10, 2020

Ingredients

Folic acidActive

Code: 935E97BOY8Class: ACTIBQuantity: 1 mg in 1 1

Vitamin CActive

Code: PQ6CK8PD0RClass: ACTIBQuantity: 125 mg in 1 1

ThiamineActive

Code: M572600E5PClass: ACTIBQuantity: 25 mg in 1 1

MecobalaminActive

Code: BR1SN1JS2WClass: ACTIBQuantity: 1 mg in 1 1

NicotinamideActive

Code: 25X51I8RD4Class: ACTIBQuantity: 60 mg in 1 1

PyridoxineActive

Code: KV2JZ1BI6ZClass: ACTIBQuantity: 12.5 mg in 1 1

.beta.-d-riboseActive

Code: IVV837V11NClass: ACTIBQuantity: 50 mg in 1 1

Coenzyme Q10Active

Code: EJ27X76M46Class: ACTIBQuantity: 75 mg in 1 1

MICROCRYSTALLINE CELLULOSEInactive

Code: OP1R32D61UClass: IACT

MAGNESIUM STEARATEInactive

Code: 70097M6I30Class: IACT

SILICON DIOXIDEInactive

Code: ETJ7Z6XBU4Class: IACT

AI-Powered Research

Premium Access

Zyrexal

FDA Approval Summary

Products1

Zyrexal

Product Details